Abstract:Background: Increasing evidence indicates the importance of CD8 + T cells in autoimmune attack against CNS myelin and axon in multiple sclerosis (MS). Previous research has also discovered that myelin-reactive T cells have memory phenotype functions in MS patients. However, limited evidence is available regarding the role of CD8 + memory T cell subsets in MS. This study aimed to explore potential antigen-specific memory T cell-related biomarkers and their association with disease activity. Methods: The myelin oligodendrocyte glycoprotein (MOG)-specific CD8 + memory T cell subsets and their related cytokines (perforin, granzyme B, interferon (IFN)-γ) and negative co-stimulatory molecules (programmed cell death protein 1 (PD-1), T- cell Ig and mucin domain 3 (Tim-3)) were analyzed by flow cytometry and real-time PCR in peripheral blood of patients with relapsing-remitting MS. Results: We found that MS patients had elevated frequency of MOG-specific CD8 + T cells, MOG-specific central memory T cells (T CM ), MOG-specific CD8 + effector memory T cells (T EM ), and MOG-specific CD8 + terminally differentiated cells (T EMRA ); elevated granzyme B expression on MOG-specific CD8 + T CM ; and, on MOG-specific CD8 + T EM , elevated granzyme B and reduced PD-1 expression. The Expanded Disability Status Scale score (EDSS) in MS patients was correlated with the frequency of MOG-specific CD8 + T CM , granzyme B expression in CD8 + T CM , and granzyme B and perforin expression on CD8 + T EM , but with reduced PD-1 expression on CD8 + T EM . Conclusion: The dysregulation of antigen-specific CD8 + memory T cell subsets, along with the abnormal expression of their related cytokines and negative co-stimulatory molecules, may reflect an excessive or persistent inflammatory response induced during early stages of the illness. Our findings strongly suggest positive regulatory roles for memory T cell populations in MS pathogenesis, probably via molecular mimicry to trigger or promote abnormal peripheral immune responses. Furthermore, downregulated PD-1 expression may stimulate a positive feedback effect, promoting MS-related inflammatory responses via the interaction of PD-1 ligands. Therefore, these parameters are potential serological biomarkers for predicting disease development in MS.

T-Cell And B-Cell Responses To Myelin-Oligodendrocyte Glycoprotein In Multiple-Sclerosis

Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls

A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion

Proteomic Profiling of Cerebrospinal Fluid in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Autoreactive T and B Cells Responding to Myelin Proteolipid Protein in Multiple Sclerosis and Controls.

Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative disease

Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

B Cells Influence Encephalitogenic T Cell Frequency to Myelin Oligodendrocyte Glycoprotein (MOG)38-49 during Full-length MOG Protein-Induced Demyelinating Disease

Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner

Interleukin-2 Secreting Cells in Multiple Sclerosis and Controls

Analysis of Myelin Oligodendrocyte Glycoprotein(mog) Antibody in Patients with Multiple Sclerosis(ms) and Its Significance

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis

Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein.

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.

A Comparative Analysis of B Cell-Mediated Myelin Oligodendrocyte Glycoprotein-Experimental Autoimmune Encephalomyelitis Pathogenesis in B Cell-Deficient Mice Reveals an Effect on Demyelination

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity

Humoral signatures of MOG-antibody-associated disease track with age and disease activity

Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease

The Imbalance Between Regulatory and Memory B Cells Accompanied by an Increased Number of Circulating T-follicular Helper Cells in MOG-antibody-associated Demyelination.